Concepedia

Vikram Arya

VA

24

Publications

813

Citations

16

H-Index

2003

Active since

Affiliations

Center for Drug Evaluation and Research(Current)

United States Food and Drug Administration

University of Florida

University of Manchester

American Association of Colleges of Pharmacy

Vikram Arya is an author at Center for Drug Evaluation and Research specializing in medicine, pharmacology, and pharmacotherapy.

ORCID

Top concepts

Publications per year

2003–2022

24

Publications

24

Comparing Various In Vitro Prediction Criteria to Assess the Potential of a New Molecular Entity to Inhibit Organic Anion Transporting Polypeptide 1B1

Jayabharathi Vaidyanathan, Kenta Yoshida, Vikram Arya et al. · The Journal of Clinical Pharmacology · 2016 · 107 citations · Full text

Population Pharmacokinetics and Pharmacodynamics of Ciclesonide

Shashank Rohatagi, Vikram Arya, Karl Zech et al. · The Journal of Clinical Pharmacology · 2003 · 105 citations

Evaluation of Exposure Change of Nonrenally Eliminated Drugs in Patients With Chronic Kidney Disease Using Physiologically Based Pharmacokinetic Modeling and Simulation

Ping Zhao, Manuela de Lima Toccafondo Vieira, Joseph A. Grillo et al. · The Journal of Clinical Pharmacology · 2012 · 96 citations

Slow Release Formulations of Inhaled Rifampin

Intira Coowanitwong, Vikram Arya, Poj Kulvanich et al. · The AAPS Journal · 2008 · 79 citations · Full text

, , +3

Review of P‐gp Inhibition Data in Recently Approved New Drug Applications: Utility of the Proposed [I<sub>1</sub>]/IC<sub>50</sub> and [I<sub>2</sub>]/IC<sub>50</sub> Criteria in the P‐gp Decision Tree

Sheetal Agarwal, Vikram Arya, Lei Zhang · The Journal of Clinical Pharmacology · 2012 · 60 citations

, , +15

Rows per page

1–5 of 24